Simplex Trading’s iTeos Therapeutics ITOS Stock Holding History

Simplex Trading’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-239,300	Closed	-$2.38M	–	9511
2025 Q2	$2.38M	Buy	239,300 +239,000	+79,667%	+$1.93M	﹤0.01%	1943
2025 Q1	$1K	Sell	300 -59,500	-99%	-$437K	﹤0.01%	8226
2024 Q4	$459K	Buy	59,800 +58,800	+5,880%	+$505K	﹤0.01%	3634
2024 Q3	$10K	Sell	1,000 -17,800	-95%	-$272K	﹤0.01%	7188
2024 Q2	$278K	Sell	18,800 -3,600	-16%	-$51.6K	﹤0.01%	4317
2024 Q1	$305K	Sell	22,400 -40,500	-64%	-$441K	﹤0.01%	4372
2023 Q4	$688K	Buy	62,900 +20,800	+49%	+$206K	﹤0.01%	3379
2023 Q3	$460K	Buy	42,100 +40,600	+2,707%	+$519K	﹤0.01%	3500
2023 Q2	$19K	Sell	1,500 -4,400	-75%	-$62.7K	﹤0.01%	6830
2023 Q1	$80K	Buy	5,900 +5,700	+2,850%	+$102K	﹤0.01%	5411
2022 Q4	$3K	Buy	+200	New	+$3.91K	﹤0.01%	8376
2022 Q3	–	Sell	-15,700	Closed	-$323K	–	10380
2022 Q2	$323K	Buy	+15,700	New	+$373K	﹤0.01%	4005

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Simplex Trading's ITOS Position: Q3 2025 in Review

Simplex Trading sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 103,212 shares — an estimated $1.03M sold.

Simplex Trading first reported a position in ITOS in Q2 2022 and held it in 9 quarters. The position peaked at $1.03M in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

Simplex Trading reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
Simplex Trading sold 103,212 iTeos Therapeutics shares in Q3 2025, an estimated $1.03M.
Simplex Trading first reported a position in iTeos Therapeutics in Q2 2022 and held it in 9 quarters.
Simplex Trading's iTeos Therapeutics position peaked at $1.03M in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.